Merck & Co., Inc. (MRK)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 11:11AM EDT. Market open.
| Previous close | 130.12 |
| Open | 131.72 |
| Bid | 130.39 x 900 |
| Ask | 130.39 x 900 |
| Day's range | 129.76 - 130.92 |
| 52-week range | 99.14 - 133.10 |
| Volume | |
| Avg. volume | 8,403,666 |
| Market cap | 329.104B |
| Beta (5Y monthly) | 0.40 |
| PE ratio (TTM) | 144.36 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 3.08 (2.37%) |
| Ex-dividend date | 14 Mar 2024 |
| 1y target est | N/A |
- Insider Monkey
Merck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript
Merck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript April 25, 2024 Merck & Co., Inc. beats earnings expectations. Reported EPS is $2.07, expectations were $1.94. Merck & Co., Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank […]
- Simply Wall St.
Merck & Co., Inc. (NYSE:MRK) Just Released Its First-Quarter Earnings: Here's What Analysts Think
Merck & Co., Inc. ( NYSE:MRK ) just released its quarterly report and things are looking bullish. The company beat...
- Zacks
Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales
Merck (MRK) beats first-quarter estimates for earnings and sales. The company raises its EPS range for 2024. Stock rises in pre-market.
© 2024 Yahoo. All rights reserved.